Ascletis Pharma Inc. (ASCLF)

USD 0.24

(0.0%)

Long Term Debt Summary of Ascletis Pharma Inc.

  • Ascletis Pharma Inc.'s latest annual long term debt in 2023 was 2.7 Million CNY , up 48.6% from previous year.
  • Ascletis Pharma Inc.'s latest quarterly long term debt in 2024 Q1 was - CNY , down 0.0% from previous quarter.
  • Ascletis Pharma Inc. reported annual long term debt of 1.82 Million CNY in 2022, up 54.06% from previous year.
  • Ascletis Pharma Inc. reported annual long term debt of 1.18 Million CNY in 2021, up 166.82% from previous year.
  • Ascletis Pharma Inc. reported quarterly long term debt of - CNY for 2024 Q2, down 0.0% from previous quarter.
  • Ascletis Pharma Inc. reported quarterly long term debt of 1.16 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Ascletis Pharma Inc. (2023 - 2016)

Historical Annual Long Term Debt of Ascletis Pharma Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 2.7 Million CNY 48.6%
2022 1.82 Million CNY 54.06%
2021 1.18 Million CNY 166.82%
2020 443 Thousand CNY -72.09%
2019 1.58 Million CNY 0.0%
2018 - CNY 0.0%
2017 - CNY 0.0%
2016 - CNY 0.0%

Peer Long Term Debt Comparison of Ascletis Pharma Inc.

Name Long Term Debt Long Term Debt Difference
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -92.881%
CSL Limited 11.23 Billion USD 99.976%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -33725.0%
Santhera Pharmaceuticals Holding AG 1.75 Million USD -54.146%
Propanc Biopharma, Inc. 58.64 Thousand USD -4514.44%
Mesoblast Limited 100.29 Million USD 97.302%
Marizyme, Inc. 667.12 Thousand USD -305.619%
Genus plc 228.2 Million USD 98.814%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD -22.443%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 90.124%
AXIM Biotechnologies, Inc. 5.42 Million USD 50.133%
MultiCell Technologies, Inc. 36.43 USD -7427844.002%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 95.134%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD -21.563%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -120.294%
Biomind Labs Inc. - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD -42.536%
Skye Bioscience, Inc. 171.23 Thousand USD -1480.331%
SQZ Biotechnologies Company 20.9 Million USD 87.058%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Intellipharmaceutics International Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 98.371%
Therapeutic Solutions International, Inc. 5512.00 USD -48992.888%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -740.373%
Alpha Cognition Inc. - USD -Infinity%
argenx SE 15.35 Million USD 82.376%
HST Global, Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -1704.0%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -1547.94%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 86.678%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -387.928%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -10596.075%
Endonovo Therapeutics, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
ONE Bio Corp. 592.19 Thousand USD -356.942%
Zenith Capital Corp. 4456.00 USD -60627.11%
Genscript Biotech Corporation 287.12 Million USD 99.058%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -2042.484%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -1080.16%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -1078.104%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 67.256%
BioStem Technologies, Inc. 265.63 Thousand USD -918.691%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -254223.308%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -1708.654%
Regen BioPharma, Inc. 149.61 Thousand USD -1708.654%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -1819.149%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -3282.5%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 65.396%
SYBLEU INC 300 Thousand USD -802.0%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -633.236%
Mobile Lads Corp. - USD -Infinity%
International Stem Cell Corporation 445 Thousand USD -508.09%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 66.798%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -492.123%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -133.075%
PureTech Health plc 18.25 Million USD 85.173%
Coeptis Therapeutics, Inc. 150 Thousand USD -1704.0%
IXICO plc 275 Thousand USD -884.0%
IntelGenx Technologies Corp. 11.83 Million USD 77.143%
Gelesis Holdings, Inc. 26.3 Million USD 89.715%
CSL Limited 11.23 Billion USD 99.976%
Cellectis S.A. 36.21 Million USD 92.527%